Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/DYN/Revenue

Dyne Therapeutics, Inc. (DYN) Revenue

Dyne Therapeutics, Inc. (DYN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to DYN

Source: SEC XBRL filings · For reference only · Not investment advice

More DYN financial trends

DYN Net incomeDYN Net marginDYN Gross profitDYN Gross marginDYN Operating incomeDYN Operating marginDYN Operating cash flowDYN Free cash flowDYN Capital expendituresDYN Return on equityDYN Stock buybacksDYN Dividends paidDYN Total assetsDYN Total liabilitiesDYN Shareholders’ equityDYN overview →